Attitudes Toward Use of an APOL1 Genetic Testing Chatbot in Living Kidney Donor Evaluation: A Focus Group Study
Clinical Transplantation · 2024-12 · 38 (12)
DOI: 10.1111/ctr.70026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, online erschienen am 03.12.2024. Verfasst von James L Rogers und 9 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt School of Medicine, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Apolipoprotein L1, Living Donors, Focus Groups, Kidney Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIH, Northwestern Memorial Hospital Dixon Translational Research Innovation Award.
Abstract (Originalsprache)
Background
Living kidney donor (LKD) candidates of African ancestry are increasingly asked to undergo Apolipoprotein L1 ( APOL1 ) genetic testing during the donor evaluation process to better understand their risk of kidney disease. LKD candidates’ attitudes about using a clinical chatbot on APOL1 remain unknown. This study builds on prior work to culturally adapt the Gia ® (Genetic Information Assistant) chatbot on APOL1 by assessing donor, recipient, and community member attitudes about the Gia chatbot for enhancing the integration of APOL1 testing into the LKD clinical evaluation workflow.
Methods
This study involved focus groups and a post‐focus group survey in two US cities about the APOL1 Gia chatbot. Qualitative data were analyzed via thematic analysis, and descriptive statistics were used for demographic data.
Results
We conducted 10 focus groups including 54 participants (25 LKDs, 23 community members, and 6 living donor kidney transplant recipients of African ancestry). Five themes emerged: (1) participants supported LKD candidates using the Gia chatbot before the nephrologist clinic visit, (2) participants were interested in undergoing APOL1 testing after using Gia, (3) APOL1 testing costs may influence LKD candidates’ willingness to get tested, (4) patients of African ancestry may hold varying preferences for using chatbots in the healthcare setting, and (5) individual‐level barriers may limit the use of Gia in the healthcare setting.
Conclusions
Individuals of African ancestry were highly receptive to integrating the APOL1 chatbot into LKD candidate clinical evaluation, which bodes well for integrating chatbots into the APOL1 clinical genetic testing process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vanderbilt School of Medicine, Nashville, Tennessee, USA.
- Center for Health Services and Outcomes Research, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Medstar Georgetown Transplant Institute, Georgetown University Hospital, Washington, District of Columbia, USA.
- Myriad Genetics, Salt Lake City, Utah.
- Department of Medicine, Cardiology Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Department of Medicine, Division of Nephrology and Hypertension I Department of Surgery, Division of Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
ORCID-Profile: James L Rogers, Jessica Gacki-Smith, Rochell Yacat, Catherine Wicklund, Debra Duquette, John Friedewald, Matthew Cooper, Akansha Agrawal, Elisa J Gordon
Förderung
- NIDDK NIH HHS
- NIH
- Northwestern Memorial Hospital Dixon Translational Research Innovation Award
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Rogers, J. L., Gacki-Smith, J., Yacat, R., Wicklund, C., Duquette, D., Friedewald, J., Cooper, M., Gilbert, A., Agrawal, A., & Gordon, E. J. (2024). Attitudes Toward Use of an APOL1 Genetic Testing Chatbot in Living Kidney Donor Evaluation: A Focus Group Study. Clinical Transplantation, 38(12). https://doi.org/10.1111/ctr.70026
Vancouver
Rogers JL, Gacki-Smith J, Yacat R, Wicklund C, Duquette D, Friedewald J, et al. Attitudes Toward Use of an APOL1 Genetic Testing Chatbot in Living Kidney Donor Evaluation: A Focus Group Study. Clinical Transplantation. 2024;38(12). doi:10.1111/ctr.70026
BibTeX
@article{Rogers2024,
author = {Rogers, James L and Gacki-Smith, Jessica and Yacat, Rochell and Wicklund, Catherine and Duquette, Debra and Friedewald, John and Cooper, Matthew and Gilbert, Alexander and Agrawal, Akansha and Gordon, Elisa J},
title = {Attitudes Toward Use of an APOL1 Genetic Testing Chatbot in Living Kidney Donor Evaluation: A Focus Group Study},
journal = {Clinical Transplantation},
year = {2024},
volume = {38},
number = {12},
doi = {10.1111/ctr.70026}
}
EUVIMED